Executive Board

The Society for Translational Medicine (STM), Established in Dec 11, 2012 in Hong Kong, is a global non-profit organization whose principal objective is to improve the survival and quality of life of patients by using translational medicine approaches, resources and expertise, as well as promoting collaborative research, evidence-based medicine, medical innovations and continuous medical education.

President

Rafael Rosell, MD, PhD

Director, Cancer Biology & Precision Medicine Program Catalan Institute of Oncology; Germans Trias i Pujol Health Sciences Institute and Hospital Badalona, Barcelona, Spain

Dr. Rafael Rosell is Director of the Cancer Biology and Precision Medicine Program at the Catalan Institute of Oncology, Hospital Germans Trias i Pujol (Badalona, Barcelona, Spain), Chief Scientific Officer, Chairman and Founder of Pangaea Biotech SL (Barcelona), Chief Medical Officer and President of the Dr Rosell Oncology Institute, Quirón Dexeus University Hospital (Barcelona) and Founder and President of the Molecular Oncology Research Foundation (Barcelona). He is Founder and Director of International Relations and Projects, Spanish Lung Cancer Group (SLCG) and a member of the Foundation Council and Steering Committee of the European Thoracic Oncology Platform (ETOP).

Read More

SECRETARY General


AME Publishing Company

SECRETARY


AME Publishing Company


AME Publishing Company


AME Publishing Company


AME Publishing Company